Skip to main content
. 2022 Jul 11;45(9):2118–2126. doi: 10.2337/dc21-2166

Figure 2.

Figure 2

A: Time course of mean plasma glucose concentrations during the 14 h in-house period before and after 8 weeks of treatment with sotagliflozin 400 mg or empagliflozin 25 mg. B: Weekly mean SMPG results from baseline (week −1) to week 8. Error bars represent SEM. BL, baseline (day −1); W8, end of treatment (day 56).